Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Menter

Showing results (181-190 of 298) with videos related to

Pageof 30
Sort By:
Journal of the American Academy of Dermatology|May 19, 2015
Phototherapy in dermatology: A call for actionHenry W Lim, Narumol Silpa-archa, Ugochukwu Amadi, et al.
Archives of Dermatology|January 19, 2005
Definitions of measures of effect duration for psoriasis treatmentsKenneth B Gordon, Steven R Feldman, John Y M Koo, et al.
Journal of the American Academy of Dermatology|December 15, 2010
Efficacy and safety of ABT-874, a monoclonal anti-interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trialAlexa B Kimball, Kenneth B Gordon, Richard G Langley, et al.
Dermatology and Therapy|January 29, 2021
Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated ComorbiditiesAlan Menter, Gerald G Krueger, So Yeon Paek, et al.
Journal of Drugs in Dermatology : JDD|August 3, 2007
Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgarisJoel Schlessinger, Alan Menter, Michael Gold, et al.
Anais Brasileiros De Dermatologia|August 28, 2015
Use of tumor necrosis factor alpha (TNF α) antagonists in a patient with psoriasis and Chagas diseaseCristián Navarrete-Dechent, Daniela Majerson, Marisa Torres, et al.
American Journal of Clinical Dermatology|May 26, 2017
Erratum to: Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE StudyCarle Paul, Craig Leonardi, Alan Menter, et al.
Journal of the American Academy of Dermatology|October 15, 2017
Spectrum of orocutaneous disease associations: Genodermatoses and inflammatory conditionsElizabeth G Wilder, Jillian Frieder, Suraj Sulhan, et al.
Human Molecular Genetics|August 3, 2011
Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAomeCailin E Joyce, Xiang Zhou, Jing Xia, et al.
American Journal of Clinical Dermatology|February 26, 2017
Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE StudyCarle Paul, Craig Leonardi, Alan Menter, et al.
Pageof 30

Showing results (181-190 of 298) with videos related to

Sort By:
Pageof 30
Journal of the American Academy of Dermatology|May 19, 2015
Phototherapy in dermatology: A call for actionHenry W Lim, Narumol Silpa-archa, Ugochukwu Amadi, et al.
Archives of Dermatology|January 19, 2005
Definitions of measures of effect duration for psoriasis treatmentsKenneth B Gordon, Steven R Feldman, John Y M Koo, et al.
Journal of the American Academy of Dermatology|December 15, 2010
Efficacy and safety of ABT-874, a monoclonal anti-interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trialAlexa B Kimball, Kenneth B Gordon, Richard G Langley, et al.
Dermatology and Therapy|January 29, 2021
Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated ComorbiditiesAlan Menter, Gerald G Krueger, So Yeon Paek, et al.
Journal of Drugs in Dermatology : JDD|August 3, 2007
Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgarisJoel Schlessinger, Alan Menter, Michael Gold, et al.
Anais Brasileiros De Dermatologia|August 28, 2015
Use of tumor necrosis factor alpha (TNF α) antagonists in a patient with psoriasis and Chagas diseaseCristián Navarrete-Dechent, Daniela Majerson, Marisa Torres, et al.
American Journal of Clinical Dermatology|May 26, 2017
Erratum to: Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE StudyCarle Paul, Craig Leonardi, Alan Menter, et al.
Journal of the American Academy of Dermatology|October 15, 2017
Spectrum of orocutaneous disease associations: Genodermatoses and inflammatory conditionsElizabeth G Wilder, Jillian Frieder, Suraj Sulhan, et al.
Human Molecular Genetics|August 3, 2011
Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAomeCailin E Joyce, Xiang Zhou, Jing Xia, et al.
American Journal of Clinical Dermatology|February 26, 2017
Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE StudyCarle Paul, Craig Leonardi, Alan Menter, et al.
Pageof 30